138 related articles for article (PubMed ID: 37930075)
1. Influenza virus cell entry and targeted antiviral development.
Zhu M; Anirudhan V; Du R; Rong L; Cui Q
J Med Virol; 2023 Nov; 95(11):e29181. PubMed ID: 37930075
[TBL] [Abstract][Full Text] [Related]
2. Influenza Virus Entry inhibitors.
Yang J; Liu S
Adv Exp Med Biol; 2022; 1366():123-135. PubMed ID: 35412138
[TBL] [Abstract][Full Text] [Related]
3. Perspective of Use of Antiviral Peptides against Influenza Virus.
Skalickova S; Heger Z; Krejcova L; Pekarik V; Bastl K; Janda J; Kostolansky F; Vareckova E; Zitka O; Adam V; Kizek R
Viruses; 2015 Oct; 7(10):5428-42. PubMed ID: 26492266
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
5. Non-Steroidal Estrogens Inhibit Influenza Virus by Interacting with Hemagglutinin and Preventing Viral Fusion.
Franzi E; Mathez G; Dinant S; Deloizy C; Kaiser L; Tapparel C; Le Goffic R; Cagno V
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895062
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
Bioorg Med Chem; 2019 Dec; 27(23):115147. PubMed ID: 31635892
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Peptides as Anti-Influenza Agents.
Agamennone M; Fantacuzzi M; Vivenzio G; Scala MC; Campiglia P; Superti F; Sala M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232735
[TBL] [Abstract][Full Text] [Related]
8. Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
Shen W; Wang Q; Wang Z; Liu M; Du Y; Yuan L; Han L; Smietanka K; Chen H; Xu S; Zhu Q
J Virol; 2022 Sep; 96(18):e0123822. PubMed ID: 36037479
[TBL] [Abstract][Full Text] [Related]
9. New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides.
Wu W; Lin D; Shen X; Li F; Fang Y; Li K; Xun T; Yang G; Yang J; Liu S; He J
PLoS One; 2015; 10(9):e0138426. PubMed ID: 26382764
[TBL] [Abstract][Full Text] [Related]
10. Influenza A virus entry inhibitors targeting the hemagglutinin.
Yang J; Li M; Shen X; Liu S
Viruses; 2013 Jan; 5(1):352-73. PubMed ID: 23340380
[TBL] [Abstract][Full Text] [Related]
11. Ching-fang-pai-tu-san inhibits the release of influenza virus.
Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
[TBL] [Abstract][Full Text] [Related]
12. Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means.
Terrier O; Slama-Schwok A
Adv Exp Med Biol; 2021; 1322():195-218. PubMed ID: 34258742
[TBL] [Abstract][Full Text] [Related]
13. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Inhibitory Effect of AgBiS
Yang J; Yue L; Shen B; Yang Z; Shao J; Miao Y; Ouyang R; Hu Y
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373369
[TBL] [Abstract][Full Text] [Related]
15. Investigational hemagglutinin-targeted influenza virus inhibitors.
Zeng LY; Yang J; Liu S
Expert Opin Investig Drugs; 2017 Jan; 26(1):63-73. PubMed ID: 27918208
[TBL] [Abstract][Full Text] [Related]
16. An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein.
Yoon A; Yi KS; Chang SY; Kim SH; Song M; Choi JA; Bourgeois M; Hossain MJ; Chen LM; Donis RO; Kim H; Lee Y; Hwang DB; Min JY; Chang SJ; Chung J
PLoS One; 2015; 10(10):e0141312. PubMed ID: 26512723
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the infectivity and inflammatory response of influenza virus by Arbidol hydrochloride in vitro and in vivo (mice and ferret).
Wang Y; Ding Y; Yang C; Li R; Du Q; Hao Y; Li Z; Jiang H; Zhao J; Chen Q; Yang Z; He Z
Biomed Pharmacother; 2017 Jul; 91():393-401. PubMed ID: 28475918
[TBL] [Abstract][Full Text] [Related]
18. Broadly neutralizing antibodies recognizing different antigenic epitopes act synergistically against the influenza B virus.
Zhai L; Zhang L; Jiang Y; Li B; Yang M; Victorovich KV; Aleksandrovna KT; Li M; Wang Y; Huang D; Zeng Z; Ren Z; Cao H; Zhu L; Wu Q; Xiao W; Zhang B; Wan C; Wang F; Xia N; Zhao W; Chen Y; Shen C
J Med Virol; 2023 Jan; 95(1):e28106. PubMed ID: 36039848
[TBL] [Abstract][Full Text] [Related]
19. Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance.
Bai Y; Jones JC; Wong SS; Zanin M
Viruses; 2021 Apr; 13(4):. PubMed ID: 33917376
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of influenza virus infection and hemagglutinin cleavage by the protease inhibitor HAI-2.
Hamilton BS; Chung C; Cyphers SY; Rinaldi VD; Marcano VC; Whittaker GR
Biochem Biophys Res Commun; 2014 Jul; 450(2):1070-5. PubMed ID: 24978308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
